Willow Biosciences Inc. (WLLW.TO) (TSE:WLLW) and Khiron Life Sciences Corp. (KHRN.V) (CVE:KHRN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.
Valuation and Earnings
This table compares Willow Biosciences Inc. (WLLW.TO) and Khiron Life Sciences Corp. (KHRN.V)'s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Willow Biosciences Inc. (WLLW.TO) | C$2,360.00 | 78,260.42 | C$-32,036,529.00 | C($0.28) | -5.77 |
Khiron Life Sciences Corp. (KHRN.V) | C$8.01 million | 10.31 | C$-39,493,921.00 | C($0.26) | -2.09 |
Willow Biosciences Inc. (WLLW.TO) has higher earnings, but lower revenue than Khiron Life Sciences Corp. (KHRN.V). Willow Biosciences Inc. (WLLW.TO) is trading at a lower price-to-earnings ratio than Khiron Life Sciences Corp. (KHRN.V), indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Willow Biosciences Inc. (WLLW.TO) and Khiron Life Sciences Corp. (KHRN.V)'s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Willow Biosciences Inc. (WLLW.TO) | N/A | N/A | N/A |
Khiron Life Sciences Corp. (KHRN.V) | N/A | N/A | N/A |
Analyst Ratings
This is a summary of recent recommendations and price targets for Willow Biosciences Inc. (WLLW.TO) and Khiron Life Sciences Corp. (KHRN.V), as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Willow Biosciences Inc. (WLLW.TO) | 0 | 0 | 0 | 0 | N/A |
Khiron Life Sciences Corp. (KHRN.V) | 0 | 0 | 0 | 0 | N/A |
Willow Biosciences Inc. (WLLW.TO) presently has a consensus target price of C$2.75, suggesting a potential upside of 69.75%. Khiron Life Sciences Corp. (KHRN.V) has a consensus target price of C$1.20, suggesting a potential upside of 118.18%. Given Khiron Life Sciences Corp. (KHRN.V)'s higher probable upside, analysts clearly believe Khiron Life Sciences Corp. (KHRN.V) is more favorable than Willow Biosciences Inc. (WLLW.TO).
Summary
Khiron Life Sciences Corp. (KHRN.V) beats Willow Biosciences Inc. (WLLW.TO) on 4 of the 6 factors compared between the two stocks.